Azelby Robert — SEC Form 4 filings
SEC reporting owner CIK 1656998. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-18 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 6,995 shares, $20,216 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 6,995 shares @ $2.89 ($20,216) in ADC Therapeutics SA, filed 2024-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ADC Therapeutics SA (ADCT) | Director | 5 | — | 1 leg · 6,995 sh · $20,216 | 5 |
| Terns Pharmaceuticals, Inc. (TERN) | Director | 3 | — | — | 4 |
| CARDINAL HEALTH INC (CAH) | Director | 3 | — | — | 3 |
| Autolus Therapeutics plc (AUTL) | Director | 1 | — | — | 2 |
| Tango Therapeutics, Inc. (TNGX) | Director | 1 | — | — | 2 |
Form 4 filings — Azelby Robert
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Autolus Therapeutics plc (AUTL) | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 5,740 @ $0 · Grant/award (A): 35,910 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | ADC Therapeutics SA (ADCT) | Grant/award (A): 45,000 @ $0 · Tax withholding (F): 12,600 @ $3.08 | EDGAR |
| 2026-05-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 1,697 (derivative) | EDGAR |
| 2026-02-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 1,697 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | CARDINAL HEALTH INC (CAH) | Grant/award (A): 1,067 @ $0 | EDGAR |
| 2025-06-17 | 4 | ADC Therapeutics SA (ADCT) | Tax withholding (F): 12,600 @ $3.58 | EDGAR |
| 2025-06-05 | 4 | ADC Therapeutics SA (ADCT) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-02-24 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2024-11-07 | 4 | CARDINAL HEALTH INC (CAH) | Grant/award (A): 1,730 @ $0 | EDGAR |
| 2024-06-18 | 4 | ADC Therapeutics SA (ADCT) | Sale (S): 6,995 @ $2.89 | EDGAR |
| 2024-06-14 | 4 | ADC Therapeutics SA (ADCT) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2024-03-18 | 4 | CARDINAL HEALTH INC (CAH) | Grant/award (A): 1,288 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1656998 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →